Jasper Therapeutics, Inc.
Clinical trials sponsored by Jasper Therapeutics, Inc., explained in plain language.
-
New drug tested for stubborn cold and pressure hives
Disease control TerminatedThis early-stage trial tested a single dose of an experimental drug called briquilimab in adults with chronic hives triggered by cold or friction. The main goal was to check the drug's safety and see if it could help people whose hives aren't controlled by standard allergy medici…
Phase: PHASE1, PHASE2 • Sponsor: Jasper Therapeutics, Inc. • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC
-
Early asthma drug trial halted after testing in small group
Disease control TerminatedThis was an early, small study to see if a single dose of an experimental drug called briquilimab could help control allergic asthma. It tested 17 adults with mild-to-moderate asthma, comparing the drug to a placebo (dummy treatment) to see if it reduced lung tightening caused by…
Phase: PHASE1 • Sponsor: Jasper Therapeutics, Inc. • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC